Last ¥887.00 JPY
Change Today +2.00 / 0.23%
Volume 303.9K
As of 2:00 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

nipro corp (8086) Snapshot

Open
¥885.00
Previous Close
¥885.00
Day High
¥887.00
Day Low
¥884.00
52 Week High
08/5/13 - ¥998.00
52 Week Low
09/2/13 - ¥820.00
Market Cap
152.1B
Average Volume 10 Days
369.2K
EPS TTM
¥17.04
Shares Outstanding
171.5M
EX-Date
09/26/14
P/E TM
52.1x
Dividend
¥26.50
Dividend Yield
3.44%
Current Stock Chart for NIPRO CORP (8086)

Related News

No related news articles were found.

nipro corp (8086) Related Businessweek News

View More BusinessWeek News

nipro corp (8086) Details

Nipro Corporation, together with its subsidiaries, is engaged in the medical equipment, pharmaceuticals, and glass businesses. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, dialysis products, advanced products, and diabetes products. Its Pharmaceutical-Related Business segment provides generic drugs, injectable drugs; oral drugs; injection kit products; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass for lighting purposes. Nipro Corporation is also involved in the rental of real estate properties. It operates primarily in Japan, Europe, rest of Asia, and the United States of America. The company was founded in 1954 and is headquartered in Osaka, Japan.

21,826 Employees
Last Reported Date: 06/26/14
Founded in 1954

nipro corp (8086) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nipro corp (8086) Key Developments

Nipro Corporation Reports Consolidated and Unconsolidated Earnings Results for Year Ended March 31, 2014; Provides Earning Guidance for Six Months Ending September 30, 2014 and Full Year Ending March 31, 2015; Provides Dividend Guidance for the Second Quarter Ending September 30, 2014 and Full Year Ending March 31, 2015; Announces Dividend for the Year Ended March 31, 2014, Payable on June 27, 2014

Nipro Corporation reported consolidated and unconsolidated earnings results for year ended March 31, 2014. For the full year, the company reported operating income of ¥12,289 million and net income of ¥2,861 million or ¥18.19 per share on net sales of ¥300,752 million against operating income of ¥11,370 million and net income of ¥10,231 million or ¥59.99 per share on net sales of ¥241,020 million for the same period a year ago. Ordinary income was ¥11,918 million compared to ¥14,363 million in the same period last year. Income before income taxes and minority interests was ¥12,891 million against ¥18,058 million a year ago. Income before minority interests was ¥3,102 million against ¥10,619 million a year ago. Net cash provided by operating activities was ¥21,552 million compared to ¥22,593 million in the same period last year. Payments for purchase of investment securities were ¥12,025 million compared to ¥3,552 million in the same period last year. Diluted earnings per share were ¥16.29 against ¥54.12 a year ago. Payments for purchase of noncurrent assets were ¥29,239 million against ¥37,794 million a year ago. For the full year, on unconsolidated basis the company reported operating income of ¥14,774 million and net income of ¥11,345 million or ¥72.79 per share on net sales of ¥188,504 million against operating income of ¥10,438 million and net income of ¥9,856 million or ¥57.79 per share on net sales of ¥144,965 million for the same period a year ago. Ordinary income was ¥18,084 million compared to ¥13,971 million in the same period last year. Income before income taxes was ¥18,347 million against ¥16,052 million a year ago. Diluted earnings per share were ¥64.58 against ¥52.13 a year ago. The company forecasts of consolidated financial results for six months ending September 30, 2014. The company expects operating income of ¥7,800 million and net income of ¥2,150 million or ¥14.26 per share on net sales of ¥155,000 million, and ordinary income of ¥6,300 million. The company forecasts of consolidated financial results for the year ending March 31, 2015. The company expects operating income of ¥20,000 million and net income of ¥6,700 million or ¥44.45 per share on net sales of ¥330,000 million, and ordinary income of ¥16,700 million. The company declared year end dividend of ¥14.50 per share for the year ended March 31, 2014 compared to year end dividend of ¥15.50 per share paid for the year ended March 31, 2013. The payment date of cash dividend is June 27, 2014. The company provided dividend guidance for the second quarter ending September 30, 2014 and full year ending March 31, 2015. For the quarter, the company forecasts dividend of ¥13.50 per share. For the year ending March 31, 2015, the company forecasts dividend of ¥13.00 per share.

Nipro Corporation, Annual General Meeting, Jun 26, 2014

Nipro Corporation, Annual General Meeting, Jun 26, 2014.

Nipro Corporation to Report Fiscal Year 2014 Results on May 14, 2014

Nipro Corporation announced that they will report fiscal year 2014 results on May 14, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8086:JP ¥887.00 JPY +2.00

8086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $76.09 USD -0.25
Fresenius Medical Care AG & Co KGaA €50.62 EUR +0.62
JMS Co Ltd ¥297.00 JPY -1.00
Nikkiso Co Ltd ¥1,232 JPY -1.00
NxStage Medical Inc $13.73 USD +0.23
View Industry Companies
 

Industry Analysis

8086

Industry Average

Valuation 8086 Industry Range
Price/Earnings 55.1x
Price/Sales 0.4x
Price/Book 1.1x
Price/Cash Flow 53.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.